Model‐Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes
This analysis reports a quantitative modeling and simulation approach for oral dapagliflozin, a primarily uridine diphosphate‐glucuronosyltransferase (UGT)-metabolized human sodium‐glucose cotransporter 2 selective inhibitor. A mechanistic dapagliflozin physiologically based pharmacokinetic (PBPK) m...
Saved in:
Main Authors: | Heeseung Jo (Author), Venkatesh Pilla Reddy (Author), Joanna Parkinson (Author), David W. Boulton (Author), Weifeng Tang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model
by: Victor Sokolov, et al.
Published: (2023) -
Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling
by: Victor Sokolov, et al.
Published: (2020) -
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
by: Kim HC, et al.
Published: (2023) -
Clinical studies of dapagliflozin in pediatric patients: a rapid review
by: Paige M. Grube, et al.
Published: (2022) -
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes
by: Victor Sokolov, et al.
Published: (2023)